| Drug Name |
Tiagabine hydrochloride |
| Drug ID |
BADD_D02211 |
| Description |
Tiagabine is an anti-convulsive medication. It is also used in the treatment for panic disorder as are a few other anticonvulsants. Though the exact mechanism by which tiagabine exerts its effect on the human body is unknown, it does appear to operate as a selective GABA reuptake inhibitor. |
| Indications and Usage |
For the treatment of partial seizures |
| Marketing Status |
approved; investigational |
| ATC Code |
N03AG06 |
| DrugBank ID |
DB00906
|
| KEGG ID |
D02097
|
| MeSH ID |
D000078308
|
| PubChem ID |
91274
|
| TTD Drug ID |
D0ED7U
|
| NDC Product Code |
63459-416; 63459-412; 82019-0004; 16714-151; 0093-5031; 0093-8072; 63459-404; 72205-086; 16714-153; 29902-0004; 62756-224; 72205-085; 16714-152; 16714-154; 63459-402; 69766-061; 0093-8076; 72205-084; 0093-5030; 62756-200; 72205-087 |
| UNII |
DQH6T6D8OY
|
| Synonyms |
Tiagabine | N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid | Gabitril | NO 329 | NO-329 | Tiagabine Hydrochloride | (R)-(4,4-bis(3-Methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, Hydrochloride | Tiagabine, (S)-isomer | NO 328 | NO-328 |
